These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis. Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of a Binuclear Cyclopalladated Compound Therapy for Cutaneous Leishmaniasis in the Murine Model of Infection with Leishmania amazonensis and Its Inhibitory Effect on Topoisomerase 1B. Velásquez AMA; Ribeiro WC; Venn V; Castelli S; Camargo MS; de Assis RP; de Souza RA; Ribeiro AR; Passalacqua TG; da Rosa JA; Baviera AM; Mauro AE; Desideri A; Almeida-Amaral EE; Graminha MAS Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507113 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the in vitro and in vivo antileishmanial activity of a chloroquinolin derivative against Leishmania species capable of causing tegumentary and visceral leishmaniasis. Soyer TG; Mendonça DVC; Tavares GSV; Lage DP; Dias DS; Ribeiro PAF; Perin L; Ludolf F; Coelho VTS; Ferreira ACG; Neves PHAS; Matos GF; Chávez-Fumagalli MA; Coimbra ES; Pereira GR; Coelho EAF; Antinarelli LMR Exp Parasitol; 2019 Apr; 199():30-37. PubMed ID: 30817917 [TBL] [Abstract][Full Text] [Related]
6. Antileishmanial activity of essential oil and 6,7-dehydroroyleanone isolated from Tetradenia riparia. Demarchi IG; Thomazella MV; de Souza Terron M; Lopes L; Gazim ZC; Cortez DA; Donatti L; Aristides SM; Silveira TG; Lonardoni MV Exp Parasitol; 2015 Oct; 157():128-37. PubMed ID: 26116864 [TBL] [Abstract][Full Text] [Related]
7. Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species. Valadares DG; Duarte MC; Oliveira JS; Chávez-Fumagalli MA; Martins VT; Costa LE; Leite JP; Santoro MM; Régis WC; Tavares CA; Coelho EA Parasitol Int; 2011 Dec; 60(4):357-63. PubMed ID: 21723957 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of lapachol on treatment of cutaneous and visceral leishmaniasis. Araújo IAC; de Paula RC; Alves CL; Faria KF; Oliveira MM; Mendes GG; Dias EMFA; Ribeiro RR; Oliveira AB; Silva SMD Exp Parasitol; 2019 Apr; 199():67-73. PubMed ID: 30797783 [TBL] [Abstract][Full Text] [Related]
9. Poloxamer 407 (Pluronic(®) F127)-based polymeric micelles for amphotericin B: In vitro biological activity, toxicity and in vivo therapeutic efficacy against murine tegumentary leishmaniasis. Mendonça DV; Lage LM; Lage DP; Chávez-Fumagalli MA; Ludolf F; Roatt BM; Menezes-Souza D; Faraco AA; Castilho RO; Tavares CA; Barichello JM; Duarte MC; Coelho EA Exp Parasitol; 2016 Oct; 169():34-42. PubMed ID: 27427166 [TBL] [Abstract][Full Text] [Related]
10. Microgramma vacciniifolia Frond Lectin: In Vitro Anti-leishmanial Activity and Immunomodulatory Effects Against Internalized Amastigote Forms of Leishmania amazonensis. de Souza Aguiar LM; de Moraes Alves MM; Sobrinho Júnior EPC; Paiva PMG; de Amorim Carvalho FA; de Albuquerque LP; de Siqueira Patriota LL; Napoleão TH Acta Parasitol; 2023 Dec; 68(4):869-879. PubMed ID: 37874484 [TBL] [Abstract][Full Text] [Related]
11. Antileishmanial activity of a naphthoquinone derivate against promastigote and amastigote stages of Leishmania infantum and Leishmania amazonensis and its mechanism of action against L. amazonensis species. Mendonça DVC; Lage DP; Calixto SL; Ottoni FM; Tavares GSV; Ludolf F; Chávez-Fumagalli MA; Schneider MS; Duarte MC; Tavares CAP; Alves RJ; Coimbra ES; Coelho EAF Parasitol Res; 2018 Feb; 117(2):391-403. PubMed ID: 29248978 [TBL] [Abstract][Full Text] [Related]
13. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis. Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158 [TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo Anti-leishmanial Potential of [Ag (PTA) 4 ]BF 4 and [Ag(HBPz 3 )(PPh 3 )] Silver Complexes. Soldera PF; Chagas AFDS; Brasil AMV; Comandolli-Wyrepkowski CD; Porchia M; Pereira AMRF Rev Soc Bras Med Trop; 2022; 55():e04782021. PubMed ID: 35416873 [TBL] [Abstract][Full Text] [Related]
15. Aryl thiosemicarbazones: In vitro and immunomodulatory activities against L. amazonensis. da Silva AC; Dos Santos TAR; da Silva IVB; de Oliveira MVG; Moreira DRM; Leite ACL; Pereira VRA Exp Parasitol; 2017 Jun; 177():57-65. PubMed ID: 28433563 [TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo antileishmanial activity of a fluoroquinoline derivate against Leishmania infantum and Leishmania amazonensis species. Tavares GSV; Mendonça DVC; Lage DP; Antinarelli LMR; Soyer TG; Senna AJS; Matos GF; Dias DS; Ribeiro PAF; Batista JPT; Poletto JM; Brandão GC; Chávez-Fumagalli MA; Pereira GR; Coimbra ES; Coelho EAF Acta Trop; 2019 Mar; 191():29-37. PubMed ID: 30586571 [TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo activity of a palladacycle complex on Leishmania (Leishmania) amazonensis. Paladi Cde S; Pimentel IA; Katz S; Cunha RL; Judice WA; Caires AC; Barbiéri CL PLoS Negl Trop Dis; 2012; 6(5):e1626. PubMed ID: 22616018 [TBL] [Abstract][Full Text] [Related]